 CRANBURY, N.J.--BUSINESS WIRE--Rocket Pharmaceuticals, Inc. NASDAQ: RCKT, a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces data presentations at the 28th Annual Congress of the European Society of Gene Cell Therapy ESGCT taking place virtually October 19-22, 2021. Oral presentations will include clinical data from Rockets lentiviral vector LVV-based gene therapy programs for Leukocyte Adhe 